text.skipToContent text.skipToNavigation
Pharma & Biotech

You searched for "peripheral/lgm3.aspx"

85 Products found
  • 1(current)
  • 2
  • 3

You searched for "peripheral/lgm3.aspx"

978 Documents found
  • TechSheet - Normal Human Dendritic Cell System
    Normal Human Dendritic CellsCC-2701CD11c+CD14-CD86CD80HLA-DRCC-3182 LGM-3 Medium
  • Primary Normal Human Cells and Media
    In Vivo Relevance. In Vitro Results. Updated and revised cell content. New in print
  • Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic Research
    Lonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
  • Transfection Protocol for Human T Cells (Stim.) - 96-well ShuttleTM Device
    Instructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 96-well NucleofectorTM Kit
  • Transfection Protocol for Human T Cells (Unstim.) - 96-well ShuttleTM Device
    Instructions of use for transfection of unstimulated peripheral blood human T cells with the P3 Primary Cell 96-well NucleofectorTM Kit
  • Transfection Protocol for Human T Cells (Unstim.) - 4D-NucleofectorTM LV Unit
    Instructions of use for transfection of unstimulated peripheral blood human T cells with the P3 Primary Cell 4D-NucleofectorTM LV Kit
  • Transfection Protocol for Human T Cells (Stim.) - 4D-NucleofectorTM Device
    Instructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 4D-NucleofectorTM X Kit
  • Transfection Protocol for Human T Cells (Unstim.) - 4D-NucleofectorTM Device
    Instructions of use for transfection of unstimulated peripheral blood human T cells with the P3 Primary Cell 4D-NucleofectorTM X Kit
  • Transfection Protocol for Human Monocytes - NucleofectorTM 1/2 Device Series
    Instructions of use for transfection of human Monocytes with NucleofectorTM 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Transfection Protocol for Human NK Cells - NucleofectorTM 1/2 Device Series
    Instructions of use for transfection of human natural killer cells with NucleofectorTM 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • siRNA Transfection Protocol for Blood Lymphocytes
    Instructions of use for transfection of human peripheral blood lympohocytes with siRNA using the NucleofectorTM Technology
  • Transfection Protocol for hT Cells (stim.) - NucleofectorTM 1/2 Device Series
    Instructions of use for transfection of stimulated human peripheral blood T cells with NucleofectorTM 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Transfection Protocol for hT Cells (unstim.) - NucleofectorTM 1/2 Device Series
    Instructions of use for transfection of unstimulated human peripheral blood T cells with NucleofectorTM 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • 3D Natural Killer Cell-mediated Cytotoxicity Assay
    An in vitro model for Natural Killer (NK) cell-mediated cytotoxicity was developed using a collagen-based scaffold 3D cell culture technology. This technology induced HCT116 cells to aggregate into tumoroids over time which became the target cells during the cytotoxicity assay.
  • Bioscience Solutions Catalog 2018
    Catalog-Chapter1-Stem-Cells-2018.pdf
  • Primary Cells and Media Reference Guide
    A comprehensive collection of primary cells and media products supporting many research areas Cryopreserved Human Primary Cells Cryopreserved Animal Primary Cells Cryopreserved Hepatocytes Fresh Human and Animal Primary Cells
  • Bioscience Solutions Catalog 2018
    Catalog-Chapter3-Hepa-Products-2018.pdf
  • NIH/3T3 Transfection Protocol - 96-well ShuttleTM Device
    Instructions of use for transfection of NIH/3T3 cells with the SG Cell Line 96-well NucleofectorTM Ki
  • NIH/3T3 Transfection Protocol - 4D-NucleofectorTM Device
    Instructions of use for transfection of NIH/3T3 cells with the SG Cell Line 4D-NucleofectorTM X Kit
  • Bioscience Solutions Catalog 2018
    Catalog-Chapter2-Primary-Cells-2018.pdf
  • 1(current)
  • 2
  • 3

You searched for "peripheral/lgm3.aspx"

0 Results found
We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok